Your browser doesn't support javascript.
loading
Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency.
Pillay, Bethany A; Fusaro, Mathieu; Gray, Paul E; Statham, Aaron L; Burnett, Leslie; Bezrodnik, Liliana; Kane, Alisa; Tong, Winnie; Abdo, Chrystelle; Winter, Sarah; Chevalier, Samuel; Levy, Romain; Masson, Cécile; Schmitt, Yohann; Bole, Christine; Malphettes, Marion; Macintyre, Elizabeth; De Villartay, Jean-Pierre; Ziegler, John B; Smart, Joanne M; Peake, Jane; Aghamohammadi, Asghar; Hammarström, Lennart; Abolhassani, Hassan; Picard, Capucine; Fischer, Alain; Latour, Sylvain; Neven, Benedicte; Tangye, Stuart G; Ma, Cindy S.
Affiliation
  • Pillay BA; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Fusaro M; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales (UNSW) Sydney, New South Wales, Australia.
  • Gray PE; Paris University, Imagine Institute, Université de Paris, Paris, France.
  • Statham AL; Study Center for Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Burnett L; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, INSERM UMR 1163, Imagine Institut, Paris, France.
  • Bezrodnik L; Department of Immunology and Infectious Diseases, Sydney Children's Hospital, Sydney, Australia.
  • Kane A; School of Women's and Children's Health, UNSW Sydney, New South Wales, Australia.
  • Tong W; Clinical Immunogenomics Research Consortia of Australasia, Sydney, New South Wales, Australia.
  • Abdo C; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Winter S; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Chevalier S; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales (UNSW) Sydney, New South Wales, Australia.
  • Levy R; Clinical Immunogenomics Research Consortia of Australasia, Sydney, New South Wales, Australia.
  • Masson C; Clinical Immunology Center and Immunology Unit, Ricardo Gutiérrez Children Hospital, Ciudad Autónoma de Buenos Aires, Argentina.
  • Schmitt Y; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Bole C; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales (UNSW) Sydney, New South Wales, Australia.
  • Malphettes M; Clinical Immunogenomics Research Consortia of Australasia, Sydney, New South Wales, Australia.
  • Macintyre E; South Western Sydney Clinical School, Faculty of Medicine, UNSW Sydney, New South Wales, Australia.
  • De Villartay JP; HIV and Immunology Unit, St Vincent's Hospital, Sydney, Australia.
  • Ziegler JB; Department of Immunology, Allergy and HIV, Liverpool Hospital, Liverpool, Sydney, Australia.
  • Smart JM; Clinical Immunogenomics Research Consortia of Australasia, Sydney, New South Wales, Australia.
  • Peake J; HIV and Immunology Unit, St Vincent's Hospital, Sydney, Australia.
  • Aghamohammadi A; Biological Onco-hematology, Université de Paris, AP-HP and INEM, Paris, France.
  • Hammarström L; Paris University, Imagine Institute, Université de Paris, Paris, France.
  • Abolhassani H; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, INSERM UMR 1163, Imagine Institut, Paris, France.
  • Picard C; Pediatric Hematology and Immunology Unit, AP-HP, Paris, France.
  • Fischer A; Study Center for Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Latour S; Paris University, Imagine Institute, Université de Paris, Paris, France.
  • Neven B; Pediatric Hematology and Immunology Unit, AP-HP, Paris, France.
  • Tangye SG; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Paris, France.
  • Ma CS; Paris University, Imagine Institute, Université de Paris, Paris, France.
J Clin Invest ; 131(3)2021 02 01.
Article in En | MEDLINE | ID: mdl-33290277
ABSTRACT
Inborn errors of immunity cause monogenic immune dysregulatory conditions such as severe and recurrent pathogen infection, inflammation, allergy, and malignancy. Somatic reversion refers to the spontaneous repair of a pathogenic germline genetic variant and has been reported to occur in a number of inborn errors of immunity, with a range of impacts on clinical outcomes of these conditions. DOCK8 deficiency due to biallelic inactivating mutations in DOCK8 causes a combined immunodeficiency characterized by severe bacterial, viral, and fungal infections, as well as allergic disease and some cancers. Here, we describe the clinical, genetic, and cellular features of 3 patients with biallelic DOCK8 variants who, following somatic reversion in multiple lymphocyte subsets, exhibited improved clinical features, including complete resolution of infection and allergic disease, and cure over time. Acquisition of DOCK8 expression restored defective lymphocyte signalling, survival and proliferation, as well as CD8+ T cell cytotoxicity, CD4+ T cell cytokine production, and memory B cell generation compared with typical DOCK8-deficient patients. Our temporal analysis of DOCK8-revertant and DOCK8-deficient cells within the same individual established mechanisms of clinical improvement in these patients following somatic reversion and revealed further nonredundant functions of DOCK8 in human lymphocyte biology. Last, our findings have significant implications for future therapeutic options for the treatment of DOCK8 deficiency.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Lymphocyte Activation / Lymphocytes / Cell Differentiation / Severe Combined Immunodeficiency / Guanine Nucleotide Exchange Factors / Immunologic Memory Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Invest Year: 2021 Type: Article Affiliation country: Australia

Full text: 1 Database: MEDLINE Main subject: Lymphocyte Activation / Lymphocytes / Cell Differentiation / Severe Combined Immunodeficiency / Guanine Nucleotide Exchange Factors / Immunologic Memory Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Invest Year: 2021 Type: Article Affiliation country: Australia